178 related articles for article (PubMed ID: 6690859)
1. The potential hazard of particulate contamination of cardioplegic solutions.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
[TBL] [Abstract][Full Text] [Related]
2. Impairment of myocardial function induced by particulate contamination of cardioplegic solutions.
Robinson LA; Braimbridge MV; Hearse DJ
Adv Myocardiol; 1985; 6():503-12. PubMed ID: 3992048
[TBL] [Abstract][Full Text] [Related]
3. Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms.
Hearse DJ; Erol C; Robinson LA; Maxwell MP; Braimbridge MV
J Thorac Cardiovasc Surg; 1985 Mar; 89(3):428-38. PubMed ID: 3974278
[TBL] [Abstract][Full Text] [Related]
4. Absence of particle-induced coronary vasoconstriction during cardioplegic infusion: is it desirable to use a microfilter in the infusion line?
Munsch C; Rosenfeldt F; Chang V; Newman M; Davis B
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):473-80. PubMed ID: 1999941
[TBL] [Abstract][Full Text] [Related]
5. Particle-induced coronary vasoconstriction in the rat heart: pharmacological investigation of underlying mechanisms.
Hearse DJ; Sonmez B; Saldanha C; Braimbridge MV; Maxwell MP; Erol C
Thorac Cardiovasc Surg; 1986 Oct; 34(5):316-25. PubMed ID: 2431505
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
7. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery.
Sloots KL; Vinten-Johansen J; Dobson GP
J Thorac Cardiovasc Surg; 2007 May; 133(5):1171-8. PubMed ID: 17467425
[TBL] [Abstract][Full Text] [Related]
8. Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis.
Tait GA; Booker PD; Wilson GJ; Coles JG; Steward DJ; MacGregor DC
J Thorac Cardiovasc Surg; 1982 Jun; 83(6):824-9. PubMed ID: 6283276
[TBL] [Abstract][Full Text] [Related]
9. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
[TBL] [Abstract][Full Text] [Related]
10. Steroids and cardioplegia: effects of glucocorticoids upon vascular resistance during cardioplegic perfusion.
Sellevold OF; Jynge P
Thorac Cardiovasc Surg; 1987 Oct; 35(5):307-11. PubMed ID: 2447674
[TBL] [Abstract][Full Text] [Related]
11. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1984 Feb; 87(2):190-200. PubMed ID: 6694410
[TBL] [Abstract][Full Text] [Related]
12. Protection of the ischemic myocardium: dose-response relationships with glucocorticoids in filtered cardioplegic solutions.
Sellevold OF; Jynge P
Thorac Cardiovasc Surg; 1987 Apr; 35(2):108-14. PubMed ID: 2440131
[TBL] [Abstract][Full Text] [Related]
13. Impact of particulate contamination in crystalloid cardioplegic solutions: studies by scanning and transmission electron microscopy.
Hellinger A; Piotrowski J; Konerding MA; Burchard WG; Doetsch N; Peitgen K; Erhard J; Reidemeister JC
Thorac Cardiovasc Surg; 1997 Feb; 45(1):20-6. PubMed ID: 9089970
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
Yamamoto H; Avkiran M
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
[TBL] [Abstract][Full Text] [Related]
15. Continuous addition of adenosine with a micropump system improves warm whole blood cardioplegia.
Agnihotri AK; Recanati MA; White JK; Titus J; Fischer JI; Schon J; Torchiana DF
Heart Surg Forum; 2003; 6(4):264-72. PubMed ID: 12928212
[TBL] [Abstract][Full Text] [Related]
16. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
17. Cardioplegic solutions for myocardial preservation: analysis of hypothermic arrest, potassium arrest, and procaine arrest.
Harlan BJ; Ross D; Macmanus Q; Knight R; Luber J; Starr A
Circulation; 1978 Sep; 58(3 Pt 2):I114-8. PubMed ID: 14740690
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
Okada K; Yamashita C; Okada M; Okada M
J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
20. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
Zhou RH; Long C; Liu J; Liu B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
